Learning Objectives:
At the conclusion of this session, participants will be able to:
- Describe the clinical evidence available for the treatment of KPC-containing Enterobacteriaceae using specific cases as example.
- Outline the clinical impact and therapeutic differences between different mechanisms causing carbapenem resistance
- Review the treatment options for infections caused by GNR carrying metallo-B-lactamases in a real situation.
- Discuss the therapeutic approach for colistin-resistant microorganisms
Target Audience: Academicians, Epidemiologists, Fellows, Healthcare workers, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists
Tracks: Investigative ID, Global ID, Epidemiology and Infection Control, Adult ID
Interactive Moderators:
Cesar Arias, MD, PhD, FIDSA, University of Texas McGovern Medical School at Houston
and
Robert A. Bonomo, MD, Case Western Reserve University
Presentations:
CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™
ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE
ACPE Number: 0221-9999-16-216-L01-P
Disclosures:
C. Arias,
Forest/Actavis:
Grant Investigator
and
Speaker's Bureau
,
Research support
Theravance:
Consultant
,
Grant Investigator
and
Speaker's Bureau
,
Grant recipient
and
Speaker honorarium
Pfizer:
Grant Investigator
,
Scientific Advisor
and
Speaker's Bureau
,
Grant recipient
and
Speaker honorarium
Cubist:
Consultant
,
Grant Investigator
and
Scientific Advisor
,
Consulting fee
,
Grant recipient
and
Speaker honorarium
Bayer:
Consultant
and
Scientific Advisor
,
Consulting fee
Merck:
Grant Investigator
and
Speaker's Bureau
,
Research grant
and
Speaker honorarium
Astra-Zeneca:
Speaker's Bureau
,
Speaker honorarium
Novartis:
Speaker's Bureau
,
Speaker honorarium
The Medicines Company:
Speaker's Bureau
,
Speaker honorarium
Wockhardt: Grant Investigator , Grant recipient
Allergan: Grant Investigator , Research grant